» Articles » PMID: 31016558

Hypo-phosphorylated CD147 Promotes Migration and Invasion of Hepatocellular Carcinoma Cells and Predicts a Poor Prognosis

Overview
Publisher Springer
Date 2019 Apr 25
PMID 31016558
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: CD147 is a tumor-associated antigen that plays a key regulatory role in tumor invasion and distant metastasis. However, the exact role of CD147 phosphorylation, which is deregulated during cancer progression, is unknown. Here, the effects of CD147 phosphorylation on the malignant behavior of hepatocellular carcinoma (HCC) cells and its possible underlying mechanisms are explored.

Methods: An in situ Duolink-proximity ligation assay (PLA) was used to detect CD147 phosphorylation. Tandem mass spectrometry was employed to identify the phosphorylation sites of CD147. The effects of CD147 phosphorylation on the malignant behavior of HCC cells were evaluated using scratch wound healing assays, transwell invasion assays and cell cycle assays. The genes regulated by CD147 phosphorylation were detected by RNA sequencing.

Results: We identified phosphorylated serine-246 in the C terminus of CD147 in primary HCC tissues, whereas serine to alanine substitution mutation analysis suggested that CD147 is phosphorylated mainly at serine-252 in HCC-derived Huh-7 cells. Recovery expression of S246A/S252A mutants in CD147 knockout cells revealed significantly increased migration and invasion capacities compared to wildtype CD147 expressing cells. Cyclophilin A (CyPA) treatment decreased the phosphorylation level of CD147, whereas NIMA-related kinase 6 (NEK6) increased the CD147 phosphorylation level. Moreover, the CD147 phosphorylation level was found to be dramatically decreased in HCC tissues in patients with distant metastases, and a low phosphorylation level of CD147 was found to be associated with a high serum AFP level, recurrence and a poor overall survival.

Conclusions: From our data we conclude that hypo-phosphorylated CD147 promotes the migration and invasion of HCC cells and correlates with an unfavorable prognosis in HCC patients, indicating that targeting the aberrantly hypo-phosphorylated form of CD147 may be instrumental for the development of novel therapeutic modalities directed against HCC metastasis.

Citing Articles

BSG Isoform 2 (ENST00000353555) Is a Better Component Than Total BSG Expression in Generating Prognostic Signature for Overall Survival of Liver Cancer.

Xiong W, Deng Y Cureus. 2024; 16(6):e62287.

PMID: 39006665 PMC: 11245721. DOI: 10.7759/cureus.62287.


BSG Isoform 2 (ENST00000353555) Is a Prognostic Biomarker in Predicting Unfavorable Overall Survival of Patients With Liver Hepatocellular Carcinoma.

Xiong W, Deng Y Cureus. 2024; 16(6):e61844.

PMID: 38975467 PMC: 11227378. DOI: 10.7759/cureus.61844.


SETDB1-mediated CD147-K71 di-methylation promotes cell apoptosis in non-small cell lung cancer.

Shi M, Wang Y, Shi Y, Tian R, Chen X, Zhang H Genes Dis. 2023; 11(2):978-992.

PMID: 37692516 PMC: 10491884. DOI: 10.1016/j.gendis.2023.02.015.


Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma.

Xu Y, He H, Wu P, Li W World J Gastrointest Oncol. 2023; 15(8):1412-1423.

PMID: 37663949 PMC: 10473926. DOI: 10.4251/wjgo.v15.i8.1412.


An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning.

Guizhen Z, Weiwei Z, Yun W, Guangying C, Yize Z, Zujiang Y Front Pharmacol. 2023; 13:1096472.

PMID: 36686684 PMC: 9846167. DOI: 10.3389/fphar.2022.1096472.


References
1.
Yurchenko V, Zybarth G, OConnor M, Dai W, Franchin G, Hao T . Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem. 2002; 277(25):22959-65. DOI: 10.1074/jbc.M201593200. View

2.
Lizcano J, Deak M, Morrice N, Kieloch A, Hastie C, Dong L . Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum- and glucocorticoid-induced protein kinase in vivo. J Biol Chem. 2002; 277(31):27839-49. DOI: 10.1074/jbc.M202042200. View

3.
Belham C, Roig J, Caldwell J, Aoyama Y, Kemp B, Comb M . A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases. J Biol Chem. 2003; 278(37):34897-909. DOI: 10.1074/jbc.M303663200. View

4.
Yin M, Shao L, Voehringer D, Smeal T, Jallal B . The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J Biol Chem. 2003; 278(52):52454-60. DOI: 10.1074/jbc.M308080200. View

5.
Tang Z, Ye S, Liu Y, Qin L, Sun H, Ye Q . A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2003; 130(4):187-96. DOI: 10.1007/s00432-003-0511-1. View